JPWO2021201260A1 - - Google Patents
Info
- Publication number
- JPWO2021201260A1 JPWO2021201260A1 JP2022511147A JP2022511147A JPWO2021201260A1 JP WO2021201260 A1 JPWO2021201260 A1 JP WO2021201260A1 JP 2022511147 A JP2022511147 A JP 2022511147A JP 2022511147 A JP2022511147 A JP 2022511147A JP WO2021201260 A1 JPWO2021201260 A1 JP WO2021201260A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020067570 | 2020-04-03 | ||
| JP2020067570 | 2020-04-03 | ||
| PCT/JP2021/014253 WO2021201260A1 (ja) | 2020-04-03 | 2021-04-02 | 間葉系幹細胞の動員活性を有するペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021201260A1 true JPWO2021201260A1 (https=) | 2021-10-07 |
| JP7672636B2 JP7672636B2 (ja) | 2025-05-08 |
Family
ID=77929177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022511147A Active JP7672636B2 (ja) | 2020-04-03 | 2021-04-02 | 間葉系幹細胞の動員活性を有するペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230241159A1 (https=) |
| EP (1) | EP4144359A4 (https=) |
| JP (1) | JP7672636B2 (https=) |
| CN (1) | CN115697372A (https=) |
| BR (1) | BR112022019434A2 (https=) |
| CA (1) | CA3178719A1 (https=) |
| IL (1) | IL296982B2 (https=) |
| WO (1) | WO2021201260A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3556378B1 (en) | 2017-01-27 | 2025-03-12 | StemRIM Inc. | Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure |
| US20210024594A1 (en) | 2018-02-08 | 2021-01-28 | StemRIM Inc. | Therapeutic Agent for Psoriasis |
| US12304933B2 (en) | 2018-10-05 | 2025-05-20 | StemRIM Inc. | Disease treatment drug based on mesenchymal-stem-cell mobilization |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009133939A1 (ja) * | 2008-04-30 | 2009-11-05 | 株式会社ジェノミックス | 末梢循環への骨髄由来多能性幹細胞動員薬 |
| WO2011052668A1 (ja) * | 2009-10-28 | 2011-05-05 | 株式会社ジェノミックス | 骨髄間葉系および/または多能性幹細胞の血中動員による組織再生促進剤 |
| WO2018186480A1 (ja) * | 2017-04-07 | 2018-10-11 | 株式会社ステムリム | 線維性疾患の治療薬 |
| WO2019107530A1 (ja) * | 2017-12-01 | 2019-06-06 | 株式会社ステムリム | 炎症性腸疾患の治療薬 |
| WO2020158924A1 (ja) * | 2019-01-31 | 2020-08-06 | 国立大学法人大阪大学 | 母児間免疫寛容を誘導する方法 |
| JP7405345B2 (ja) * | 2018-10-05 | 2023-12-26 | 株式会社ステムリム | 間葉系幹細胞の動員活性を有するペプチド |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3358011T (pt) * | 2011-04-26 | 2020-04-23 | Univ Osaka | Péptido para induzir a regeneração de um tecido e a sua utilização |
| CA3059544A1 (en) * | 2017-04-25 | 2018-11-01 | Shionogi & Co., Ltd. | Peptide for inducing regeneration of tissue, and use thereof |
-
2021
- 2021-04-01 IL IL296982A patent/IL296982B2/en unknown
- 2021-04-02 BR BR112022019434A patent/BR112022019434A2/pt unknown
- 2021-04-02 US US17/995,017 patent/US20230241159A1/en active Pending
- 2021-04-02 CN CN202180032617.XA patent/CN115697372A/zh active Pending
- 2021-04-02 EP EP21781212.2A patent/EP4144359A4/en active Pending
- 2021-04-02 JP JP2022511147A patent/JP7672636B2/ja active Active
- 2021-04-02 CA CA3178719A patent/CA3178719A1/en active Pending
- 2021-04-02 WO PCT/JP2021/014253 patent/WO2021201260A1/ja not_active Ceased
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009133939A1 (ja) * | 2008-04-30 | 2009-11-05 | 株式会社ジェノミックス | 末梢循環への骨髄由来多能性幹細胞動員薬 |
| WO2011052668A1 (ja) * | 2009-10-28 | 2011-05-05 | 株式会社ジェノミックス | 骨髄間葉系および/または多能性幹細胞の血中動員による組織再生促進剤 |
| WO2018186480A1 (ja) * | 2017-04-07 | 2018-10-11 | 株式会社ステムリム | 線維性疾患の治療薬 |
| WO2019107530A1 (ja) * | 2017-12-01 | 2019-06-06 | 株式会社ステムリム | 炎症性腸疾患の治療薬 |
| JP7405345B2 (ja) * | 2018-10-05 | 2023-12-26 | 株式会社ステムリム | 間葉系幹細胞の動員活性を有するペプチド |
| WO2020158924A1 (ja) * | 2019-01-31 | 2020-08-06 | 国立大学法人大阪大学 | 母児間免疫寛容を誘導する方法 |
Non-Patent Citations (2)
| Title |
|---|
| YAMAOKA S. ET AL.: "Systemic delivery of HMGB1 peptide ameliorates imiquimod-induced psoriasis-like dermatitis", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 138(5 Supplement), JPN6019041625, May 2018 (2018-05-01), pages 177 - 1043, ISSN: 0005497271 * |
| 何 彦霆,他4名: "HMGB1 ameliorates inflammatory bowel disease by inducing circulating mesenchymal stem cells", 第17回日本再生医療学会総会 プログラム抄録[ONLINE]RETRIVED ON 2019 OCT 21, JPN6019041622, 23 February 2018 (2018-02-23), pages 34 - 2, ISSN: 0005497270 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3178719A1 (en) | 2021-10-07 |
| JP7672636B2 (ja) | 2025-05-08 |
| CN115697372A (zh) | 2023-02-03 |
| US20230241159A1 (en) | 2023-08-03 |
| BR112022019434A2 (pt) | 2022-12-06 |
| IL296982B1 (en) | 2025-12-01 |
| IL296982A (en) | 2022-12-01 |
| WO2021201260A1 (ja) | 2021-10-07 |
| EP4144359A1 (en) | 2023-03-08 |
| EP4144359A4 (en) | 2024-05-01 |
| IL296982B2 (en) | 2026-04-01 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220921 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240110 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20240424 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250107 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250218 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250403 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250410 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7672636 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |